BIOR - Biora Therapeutics Inc
IEX Last Trade
0.6973
0.012 1.649%
Share volume: 81,309
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.69
0.01
1.68%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-14 | 2023-03-30 | 2023-05-15 | 2023-08-14 | 2023-11-13 | 2024-04-01 | 2024-05-15 | |
| Assets | |||||||||
| Total Assets | 77.101 M | 62.614 M | 53.525 M | 53.243 M | 49.673 M | 34.703 M | 31.215 M | 22.990 M | |
| Current Assets | 60.145 M | 46.360 M | 38.116 M | 37.168 M | 33.885 M | 19.247 M | 19.071 M | 14.071 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 8.675 M | 6.259 M | 4.199 M | 3.368 M | 4.105 M | 3.351 M | 3.030 M | 2.429 M | |
| Short Term Investments | 8.675 M | 6.259 M | 4.199 M | 3.368 M | 4.105 M | 3.351 M | 3.030 M | 2.429 M | |
| Total Receivables | 817.000 K | 828.000 K | 828.000 K | 828.000 K | 819.000 K | 818.000 K | 830.000 K | 822.000 K | |
| Current Cash | 48.506 M | 37.060 M | 30.486 M | 30.463 M | 26.452 M | 12.569 M | 15.211 M | 10.820 M | |
| Total Non-current Assets | 16.956 M | 16.254 M | 15.409 M | 16.075 M | 15.788 M | 15.456 M | 12.144 M | 8.919 M | |
| Property Plant Equipment | 2.454 M | 2.112 M | 1.654 M | 1.498 M | 1.351 M | 1.236 M | 1.156 M | 1.136 M | |
| Other Assets | 8.430 M | 8.070 M | 7.683 M | 8.505 M | 8.365 M | 8.148 M | 4.916 M | 1.711 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 6.072 M | 6.072 M | 6.072 M | 6.072 M | 6.072 M | 6.072 M | 6.072 M | 6.072 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 77.101 M | 62.614 M | 53.525 M | 53.243 M | 49.673 M | 34.703 M | 31.215 M | 22.990 M | |
| Total liabilities | 173.207 M | 160.057 M | 155.812 M | 158.241 M | 170.554 M | 153.489 M | 132.636 M | 123.175 M | |
| Total current liabilities | 40.584 M | 27.391 M | 23.305 M | 25.083 M | 37.668 M | 69.544 M | 62.972 M | 51.104 M | |
| Accounts Payable | 4.315 M | 2.356 M | 3.606 M | 3.422 M | 5.042 M | 3.905 M | 2.843 M | 4.936 M | |
| Other liabilities | 5.537 M | 5.221 M | 4.696 M | 4.973 M | 4.318 M | 3.567 M | 25.928 M | 28.793 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.976 M | 1.976 M | |
| Long term debt | 127.086 M | 127.445 M | 127.811 M | 128.185 M | 128.568 M | 80.378 M | 43.736 M | 43.278 M | |
| Other liabilities | 5.537 M | 5.221 M | 4.696 M | 4.973 M | 4.318 M | 3.567 M | 25.928 M | 28.793 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -96.106 M | -97.443 M | -102.287 M | -104.998 M | -120.881 M | -118.786 M | -101.421 M | -100.185 M | |
| Common stock | 184.372 M | 186.954 M | -523.987 M | 10.971 M | 12.143 M | 15.025 M | 24.955 M | 29.297 M | |
| Retained earnings | -808.007 M | -813.121 M | -826.843 M | -844.284 M | -862.091 M | -935.545 M | -950.958 M | -955.147 M |